We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EME icon
576
Emcor
EME
$36.1B
$16.3M 0.03%
188,661
+8,621
+5% +$759K
CW icon
577
Curtiss-Wright
CW
$27.6B
$16.2M 0.03%
115,277
-2,350
-2% -$318K
CUZ icon
578
Cousins Properties
CUZ
$5.17B
$16.2M 0.03%
393,786
+16,939
+4% +$666K
PB icon
579
Prosperity Bancshares
PB
$9.02B
$16.2M 0.03%
225,667
+60,262
+36% +$4.26M
DAR icon
580
Darling Ingredients
DAR
$9.5B
$16.2M 0.03%
577,020
+31,791
+6% +$709K
LECO icon
581
Lincoln Electric
LECO
$14.6B
$16.2M 0.03%
167,379
+1,781
+1% +$162K
TXT icon
582
Textron
TXT
$14.9B
$16.2M 0.03%
362,709
-15,874
-4% -$735K
SBRA icon
583
Sabra Healthcare REIT
SBRA
$5.2B
$16.2M 0.03%
757,500
+34,531
+5% +$773K
KIM icon
584
Kimco Realty
KIM
$17.1B
$16.2M 0.03%
780,302
+54,773
+8% +$1.15M
TAP icon
585
Molson Coors Class B
TAP
$7.86B
$16.1M 0.03%
299,476
+8,015
+3% +$431K
NATI
586
DELISTED
National Instruments Corp
NATI
$16.1M 0.03%
380,830
-12,343
-3% -$516K
ACM icon
587
Aecom
ACM
$9.61B
$16M 0.03%
371,195
+2,828
+0.8% +$117K
TRU icon
588
TransUnion
TRU
$15.3B
$16M 0.03%
186,702
+3,819
+2% +$318K
LYV icon
589
Live Nation Entertainment
LYV
$42.3B
$16M 0.03%
223,483
-148,969
-40% -$10.1M
RHI icon
590
Robert Half
RHI
$3.96B
$15.9M 0.03%
252,524
+7,958
+3% +$462K
IRM icon
591
Iron Mountain
IRM
$36.9B
$15.9M 0.03%
499,427
+35,384
+8% +$1.16M
MKL icon
592
Markel Group
MKL
$23.3B
$15.9M 0.03%
13,878
+185
+1% +$211K
PK icon
593
Park Hotels & Resorts
PK
$3.04B
$15.9M 0.03%
613,022
-9,050
-1% -$216K
BMRN icon
594
BioMarin Pharmaceuticals
BMRN
$11.6B
$15.8M 0.03%
186,508
+5,729
+3% +$433K
MKSI icon
595
MKS Inc
MKSI
$20.9B
$15.8M 0.03%
143,169
+6,973
+5% +$731K
ABMD
596
DELISTED
Abiomed Inc
ABMD
$15.7M 0.03%
92,024
+5,572
+6% +$1.03M
JBL icon
597
Jabil
JBL
$33.4B
$15.6M 0.03%
378,567
+21,288
+6% +$817K
BURL icon
598
Burlington
BURL
$23.2B
$15.6M 0.03%
68,536
+1,283
+2% +$268K
AMCR icon
599
Amcor
AMCR
$21.3B
$15.6M 0.03%
288,232
+12,982
+5% +$650K
INVH icon
600
Invitation Homes
INVH
$18.1B
$15.6M 0.03%
519,907
+96,715
+23% +$2.9M

Similar funds

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.